The Tuberculosis Drug Accelerator at year 10: what have we learned?

Affiliations

• ¹ Tufts University, Boston, MA, USA.
• ² GlaxoSmithKline, Tres Cantos, Spain.
• ³ National Institutes of Health, Bethesda, MD, USA.
• ⁴ Panorama Global, Seattle, WA, USA.
• ⁵ University of Cape Town, Cape Town, South Africa.
• ⁶ Global Health Drug Discovery Institute, Beijing, China.
• ⁷ Global Alliance for TB Drug Development, New York, NY, USA.
• ⁸ Hackensack Meridian Health Center for Discovery & Innovation, Nutley, NJ, USA.
• ⁹ Bill & Melinda Gates Foundation, Seattle, WA, USA.
• ¹⁰ Eisai, Andover, MA, USA.
• ¹¹ Lgenia, Fortville, IN, USA.
• ¹² AbbVie, North Chicago, IL, USA.
• ¹³ Colorado State University, Fort Collins, CO, USA.
• ¹⁴ Calibr, a division of the Scripps Research Institute, La Jolla, CA, USA.
• ¹⁵ Weill Cornell Medicine, New York, NY, USA. cnathan@med.cornell.edu.
• ¹⁶ Merck & Co., West Point, PA, USA.
• ¹⁷ Seattle Children's Research Institute, Seattle, WA, USA.
• ¹⁸ Janssen-Cilag, Buckinghamshire, UK.
• ¹⁹ Weill Cornell Medicine, New York, NY, USA.
• ²⁰ The Rockefeller University, New York, NY, USA.
• ²¹ Harvard T.H. Chan School of Public Health, Boston, MA, USA.
• ²² Bill & Melinda Gates Medical Research Institute, Boston, MA, USA.
• ²³ Cornell University, Ithaca, NY, USA.
• ²⁴ Texas A&M University, College Station, TX, USA.
• ²⁵ Evotec, Lyon, France.
• ²⁶ Drug Discovery Unit, University of Dundee, Dundee, Scotland.